GlycoAvatars: Bead-Coated Membrane Models for Studying the Cancer-Immune Cells Interactome
Andréia MirandaiD, Marta Relvas‐SantosiD, Camila Lourenço, Eduardo FerreiraiD, Diogo M. CunhaiD, Carlos PalmeiraiD, Lúcio Lara SantosiD, Pieta K. MattilaiD, José Alexandre FerreiraiD
Abstract
Immature O-glycosylation of plasma membrane proteins, characterized by the presence of glycosites with a single GalNAc residue (the Tn antigen) rather than more extended and complex glycans, is a prominent feature of many advanced solid tumors across different origins and aetiologies. This form of glycosylation has been strongly associated with poor prognosis and is known to play a crucial role in the progression of the disease. Notably, it has been directly implicated in the crosstalk with the immune system, inducing tolerogenic phenotypes in both innate and adaptive immune cells. Despite this, the specific receptors involved in these interactions remain largely unidentified. To address this gap, we propose a novel high-throughput proteomics assisted strategy for characterizing the glycan interactome using plasma membrane-derived glycoprotein coated magnetic beads. Glycoproteins were isolated from plasma membranes of glycoengineered cell models with immature glycosylation and were then cloaked on the surface of magnetic beads, creating simplified cell "GlycoAvatars." These GlycoAvatars were primarily employed to characterize the interactome between gastric and colorectal cancer cell lines and immune cells (dendritic cells and macrophages), providing a tool for identifying potentially relevant molecular nodes in glycan-mediated immune synapses, foreseeing their application in deciphering tumor-immune interactions.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 2.05
- Field percentile
- top 22%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CD276 Immature Glycosylation Drives Colorectal Cancer Aggressiveness and T-cell Mediated Immune Escape
Janine Soares, Dylan Ferreira, … José Alexandre Ferreira·Cell Communication and SignalingPeer-reviewed·Jan 20, 2026
- CD44-CD206 axis drives dendritic cell loss and immunosuppression in immaturely glycosylated bladder tumours
Andréia Miranda, Dylan Ferreira, … José Alexandre Ferreira·bioRxiv·Oct 28, 2026
- Inhibition of mucin-type O-glycosylation impairs melanogenesis, melanoma growth, and metastatic capacity
Tanya Jain, Abhiraj Rajasekharan, … Srinivasa‐Gopalan Sampathkumar·bioRxiv·Oct 5, 2026
- Integrated tumour-immune cell response modelling of Luminal A breast cancer details malignant signalling and ST3Gal1 inhibitor induced reversal
Hikmet Emre Kaya, Kevin J. Naidoo·GlycobiologyPeer-reviewed·Jun 8, 2025
- Comparative analyses of the N-glycoproteomes in HCT116 cancer cells and their non-tumorigenic DNMT1/3b double knockout (DKO1) cells and insight into the Mannose-6-phosphate pathway
M. Chen, D. M. Assis, … J. C. Samuelson·bioRxiv·Jul 13, 2022
- Cancer cell glycocalyx thickness is a druggable physical phenotype for improving cellular immunotherapy
Sangwoo Park, Justin H. Paek, … Matthew J. Paszek·bioRxiv·Dec 5, 2024